Let’s connect at AMP 2025
DNAe is attending AMP 2025 in Boston, USA – and we want to meet you.
We’re heading to the Thomas M. Menino Convention & Exhibition Center in Boston from November 11th – 15th 2025 to showcase our transformative fully automated, sample-to-report diagnostics platform to the global molecular diagnostics community.
At AMP 2025, DNAe will be presenting brand-new data on our LiDia-SEQ™ platform for novel testing applications in oncology, bloodstream infection (BSI) and antimicrobial resistance (AMR) detection.
This is your chance to connect directly with our senior leadership team and learn about our game-changing LiDia-SEQ™ platform – the world’s first NGS-based diagnostic platform to fully automate the sample-to-result process within a single device.
AMP 2025 Annual Meeting & Expo is the premier meeting for molecular professionals — bringing together science, education and networking in one place to empower attendees and to advance patient care.
Poster Presentations at AMP 2025
Poster 1: Direct Detection of Bloodstream Pathogens from Whole Blood using the LiDia-SEQ™ Platform: The First, NGS-Based Sample-to-Result Platform
Category: Infectious Diseases
Presenter: Stephanie Barnes – Scientist, NGS Assay Development, DNAe
Date: Friday November 14th 2025 | 9:15am – 10:15am EST
Poster 2: Innovative technology to automate and improve the detection sensitivity of ultra-low frequency mutations directly from blood liquid biopsies
Category: Solid Tumors
Presenter: Jarrett Killpack – Future Applications Development Lead, DNAe
Date: Saturday November 15th 2025 | 9:15am – 10:15am EST
When
November 11th – 15th 2025
Where
Thomas M. Menino Convention & Exhibition Center, Boston, US
Event registration
Your Opportunity To Connect With
Sam Reed
CEO
Rishi Joshi
VP Product Management
and Business Development
